Cannabis Stock Falling With Bullish Sentiment Thursday: Should You Add Tilray Brands Inc (TLRY) To Your Portfolio?

Cannabis stock Tilray Brands Inc (TLRY) is lower by 1.93% Thursday. Tilray Brands Inc (TLRY) stock has fallen 0.56% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Tilray Brands Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TLRY!

See Full TLRY Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With TLRY Stock Today?

Tilray Brands Inc (TLRY) stock is lower by -1.93% while the S&P 500 has gained 0.03% as of 10:01 AM on Thursday, Nov 30. TLRY is down -$0.03 from the previous closing price of $1.81 on volume of 1,470,137 shares. Over the past year the S&P 500 has risen 15.01% while TLRY is down -52.15%. TLRY lost -$2.32 per share in the over the last 12 months. To screen for more stocks like Tilray Brands Inc click here.

More About Tilray Brands Inc

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. Click Here to get the full Stock Report for Tilray Brands Inc stock.